---
title: Programmatic Diagnostic Accuracy and Clinical Utility of Xpert MTB/XDR in Patients
  With Rifampicin-Resistant Tuberculosis in Georgia
date: '2025-02-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39906319/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250205170939&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Programmatic data confirm the high accuracy of Xpert MTB/XDR,
  despite being below the World Health Organization target product profile targets
  for fluoroquinolones, with significantly faster time to results than phenotypic
  ...'
disable_comments: true
---
CONCLUSIONS: Programmatic data confirm the high accuracy of Xpert MTB/XDR, despite being below the World Health Organization target product profile targets for fluoroquinolones, with significantly faster time to results than phenotypic ...